Literature DB >> 21240651

Clinical significance of nontuberculous mycobacteria isolates in elderly Taiwanese patients.

C-C Lai1, C K Tan, S H Lin, W L Liu, C H Liao, Y T Huang, P R Hsueh.   

Abstract

The aim of this study was to investigate the clinical significance of nontuberculous mycobacteria (NTM) isolates in elderly Taiwanese patients. From 2004 through 2008, patients >65 years old with NTM isolation were identified. The definitions of NTM disease followed the American Thoracic Society and Infectious Disease Society of America (ATS/IDSA) criteria. Among the 3,175 NTM isolates, Mycobacterium avium complex (MAC; n = 1,118, 35.2%) was the most prevalent species, followed by M. abscessus (n = 545, 17.2%). Among the 1,633 elderly patients with NTM isolates, the most prevalent NTM species were MAC (n = 592, 36.3%) and M. fortuitum complex (n = 311, 19.0%). NTM colonization was found in 1,339 (80.4%) patients and only 326 (19.6%) patients had NTM diseases. During the study period, the annual incidence rates (per 100,000 inpatients and outpatients) of NTM colonization and disease both increased significantly (p < 0.0001) from 10.5 to 15.8 and from 2.1 to 4.3, respectively. Isolated pulmonary NTM infections compromised 294 (90.2%) of the 326 elderly cases of NTM disease. In conclusion, this study found an increasing trend in the incidence of both NTM isolates and NTM diseases among elderly Taiwanese patients. MAC and M. abscessus were the most frequent species causing various types of NTM disease.

Entities:  

Mesh:

Year:  2011        PMID: 21240651     DOI: 10.1007/s10096-011-1155-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

Review 1.  Laboratory diagnosis of nontuberculous mycobacteria.

Authors:  Akos Somoskovi; Judit Mester; Yvonne M Hale; Linda M Parsons; Max Salfinger
Journal:  Clin Chest Med       Date:  2002-09       Impact factor: 2.878

2.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

3.  Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease.

Authors:  Kevin L Winthrop; Erin McNelley; Brian Kendall; Allison Marshall-Olson; Christy Morris; Maureen Cassidy; Ashlen Saulson; Katrina Hedberg
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

Review 4.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

5.  Nontuberculous mycobacteria in children: a changing pattern.

Authors:  Thien-Tuong-Vi Vu; Sam J Daniel; Caroline Quach
Journal:  J Otolaryngol       Date:  2005-06

Review 6.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

Review 7.  Mycobacterium tuberculosis in Taiwan.

Authors:  Po-Ren Hsueh; Yung-Ching Liu; Jen So; Cheng-Yi Liu; Pan-Chyr Yang; Kwen-Tay Luh
Journal:  J Infect       Date:  2005-10-10       Impact factor: 6.072

8.  Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman.

Authors:  Corrado Serra; Giovanni Loi; Barbara Saddi; Marisa Pautasso; Aldo Manzin
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

9.  Nontuberculous mycobacterial sensitization in the United States: national trends over three decades.

Authors:  Kamran Khan; Jun Wang; Theodore K Marras
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405

10.  The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada.

Authors:  E Hernández-Garduño; M Rodrigues; R K Elwood
Journal:  Int J Tuberc Lung Dis       Date:  2009-09       Impact factor: 2.373

View more
  6 in total

Review 1.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

2.  Identification of nontuberculous mycobacteria using multilocous sequence analysis of 16S rRNA, hsp65, and rpoB.

Authors:  Si Hyun Kim; Jeong Hwan Shin
Journal:  J Clin Lab Anal       Date:  2017-02-23       Impact factor: 2.352

3.  Mortality association of nontuberculous mycobacterial infection requiring treatment in Taiwan: a population-based study.

Authors:  Hsin-Hua Chen; Ching-Heng Lin; Wen-Cheng Chao
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

4.  Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000-2012.

Authors:  Jung-Yien Chien; Chih-Cheng Lai; Wang-Huei Sheng; Chong-Jen Yu; Po-Ren Hsueh
Journal:  Emerg Infect Dis       Date:  2014-08       Impact factor: 6.883

Review 5.  Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.

Authors:  Radha Gopalaswamy; Sivakumar Shanmugam; Rajesh Mondal; Selvakumar Subbian
Journal:  J Biomed Sci       Date:  2020-06-17       Impact factor: 8.410

6.  Comparative genome sequencing and analyses of Mycobacterium cosmeticum reveal potential for biodesulfization of gasoline.

Authors:  Wei Yee Wee; Avirup Dutta; Jayasyaliny Jayaraj; Siew Woh Choo
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.